We are live on ! Find out more
SM

SG3 Management Portfolio holdings

AUM $6.45K
1-Year Est. Return 61.81%
This Fund
S&P 500
This Quarter Est. Return
+2.7%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$746M
AUM Growth
-$106M
Cap. Flow
+$120M
Cap. Flow %
16.15%
Top 10 Hldgs %
44.28%
Holding
510
New
122
Increased
34
Reduced
58
Closed
238

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$49.5M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$21.8M
3
DIS icon
Walt Disney
DIS
+$16.1M
4
MSFT icon
Microsoft
MSFT
+$11M
5
TSM icon
TSMC
TSM
+$8.27M

Top Sells

Rank Stock Value
1
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$6.55M
2
BHC icon
Bausch Health
BHC
+$5.35M
3
DLR icon
Digital Realty Trust
DLR
+$1.95M
4
PFSI icon
PennyMac Financial
PFSI
+$1.67M
5
COP icon
ConocoPhillips
COP
+$1.62M

Sector Composition

Rank Sector Weight
1 Miscellaneous 79.32%
2 Consumer Discretionary 7.31%
3 Communication Services 4.95%
4 Technology 3.75%
5 Energy 1.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
301
CALL
AstraZeneca
AZN
$254B
– –
-46,950
Closed -$6.2M
BEKE icon
302
KE Holdings
BEKE
$18.4B
– –
-5,000
Closed -$90K
BEKE icon
303
PUT
KE Holdings
BEKE
$18.4B
– –
-30,000
Closed -$539K
BHC icon
304
Bausch Health
BHC
$2.21B
– –
-770,500
Closed -$5.35M
BHC icon
305
PUT
Bausch Health
BHC
$2.21B
– –
-770,500
Closed -$6.44M
BILI icon
306
PUT
Bilibili
BILI
$6.48B
– –
-88,600
Closed -$2.27M
BKR icon
307
CALL
Baker Hughes
BKR
$56.4B
– –
-12,000
Closed -$346K
BKR icon
308
PUT
Baker Hughes
BKR
$56.4B
– –
-30,000
Closed -$866K
BLMN icon
309
CALL
Bloomin' Brands
BLMN
$744M
– –
-300,000
Closed -$4.99M
BLMN icon
310
PUT
Bloomin' Brands
BLMN
$744M
– –
-240,000
Closed -$3.99M
BMRN icon
311
BioMarin Pharmaceuticals
BMRN
$12.9B
– –
-10,300
Closed -$917K
BMRN icon
312
PUT
BioMarin Pharmaceuticals
BMRN
$12.9B
– –
-25,000
Closed -$2.07M
BNTX icon
313
BioNTech
BNTX
$24.8B
– –
-3,000
Closed -$459K
BNTX icon
314
PUT
BioNTech
BNTX
$24.8B
– –
-35,000
Closed -$5.22M
BOX icon
315
Box
BOX
$4.63B
– –
-5,000
Closed -$126K
BP icon
316
CALL
BP
BP
$118B
– –
-13,000
Closed -$369K
BRDG
317
CALL
DELISTED
Bridge Investment Group
BRDG
– –
-25,900
Closed -$377K
BRK.B icon
318
PUT
Berkshire Hathaway Class B
BRK.B
$1.1T
– –
-2,100
Closed -$573K
CCCC icon
319
CALL
C4 Therapeutics
CCCC
$432M
– –
-77,600
Closed -$585K
CL icon
320
CALL
Colgate-Palmolive
CL
$69.2B
– –
-225,000
Closed -$18M
CLDX icon
321
CALL
Celldex Therapeutics
CLDX
$3.08B
– –
-26,000
Closed -$701K
CLDX icon
322
PUT
Celldex Therapeutics
CLDX
$3.08B
– –
-18,000
Closed -$485K
CMPS
323
Compass Pathways
CMPS
$2.01B
– –
-2,000
Closed -$22K
CMPS
324
PUT
Compass Pathways
CMPS
$2.01B
– –
-2,400
Closed -$26K
COP icon
325
ConocoPhillips
COP
$164B
– –
-18,000
Closed -$1.62M
11 12
13
14 15

Similar funds

EAM
Emso Asset Management London, United Kingdom $255K AUM 6.95% 1-Year Est. Return
CAM
Chatham Asset Management Chatham, New Jersey $376K AUM
CCM
Compton Capital Management Providence, Rhode Island $4.32M AUM 27.38% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
MAM
Moelis Asset Management New York $5.32M AUM
BGCI
Bertram Growth Capital III Foster City, California $6.05M AUM 39.41% 1-Year Est. Return
TPL
Tao Pro LLC San Francisco, California $13.8M AUM 74.14% 1-Year Est. Return
RC
Resonate Capital San Francisco, California $15.4M AUM 24.26% 1-Year Est. Return

SG3 Management's Q3 2022 Portfolio in Review

As of Q3 2022, SG3 Management held 510 positions worth $746M, down 12% from $852M the previous quarter. Its ten largest holdings account for 44% of the portfolio.

SG3 Management deployed $120M of net new capital in Q3 2022, opening 122 new positions and adding to 34 existing holdings. Its largest new stake was Tesla: 177,200 shares worth $47M.

By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 95% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was LivaNova, an estimated $1.29M trimmed.

  • SG3 Management's largest Q3 2022 buy was Tesla: 177,200 shares worth $47M.
  • SG3 Management added most to Apellis Pharmaceuticals in Q3 2022, an estimated $2.3M increase.
  • SG3 Management's biggest Q3 2022 reduction was LivaNova, cutting an estimated $1.29M.
  • SG3 Management fully exited KraneShares CSI China Internet ETF in Q3 2022, selling an estimated $6.55M.
  • SG3 Management's ten largest holdings make up 44% of its $746M portfolio in Q3 2022.
  • SG3 Management opened 122 new positions and closed 238 in Q3 2022.
  • SG3 Management's portfolio value fell 12% quarter-over-quarter to $746M.

Based on SG3 Management's 13F filing for Q3 2022, filed 14 Nov 2022.